GEN has retained its position as the number one biotech publisher around the globe since its launch in 1981, with a print edition, additional content online, and a networking platform, GENconnect. Wed, 31 Oct 2012 07:13:31 -0400 http://www.genengnews.com/media/files/rss/DRUG-DISCOVERY-lead-discovery.xml http://www.genengnews.com/gen-news-highlights/complix-awarded-2-5m-to-develop-alphabodies/81247555/ http://www.genengnews.com/gen-news-highlights/complix-awarded-2-5m-to-develop-alphabodies/81247555/ Tue, 30 Oct 2012 07:30:00 -0400